---
title: "Insmed catapults 30%, leading a biotech rally; but Mirum takes a bath"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295128466.md"
description: "Insmed stock led a biotech rally Thursday, catapulting 30% on solid second-quarter sales for its new lung disease drug, Brinsupri."
datetime: "2026-08-06T16:33:53.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295128466.md)
  - [en](https://longbridge.com/en/news/295128466.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295128466.md)
generator: "portal-rs"
---

# Insmed catapults 30%, leading a biotech rally; but Mirum takes a bath

Insmed stock led a biotech rally Thursday, catapulting 30% on solid second-quarter sales for its new lung disease drug, Brinsupri.

### Related Stocks

- [INSM.US](https://longbridge.com/en/quote/INSM.US.md)
- [MIRM.US](https://longbridge.com/en/quote/MIRM.US.md)

## Related News & Research

- [Insmed director Melvin Sharoky, M.D. sells 5,000 shares for $637,650](https://longbridge.com/en/news/296395374.md)
- [Top Insmed Executive Executes Major Multi-Million Dollar Stock Move](https://longbridge.com/en/news/295744066.md)
- [13,000 Shares in Insmed, Inc. $INSM Purchased by S&CO Inc.](https://longbridge.com/en/news/296021707.md)
- [Insmed COO Roger Adsett sells 239,850 shares for $31.97 million](https://longbridge.com/en/news/295709972.md)
- [Mirum Pharmaceuticals (MIRM) Losses Put Its Valuation Narrative Back In Focus](https://longbridge.com/en/news/296070491.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**